Results 41 to 50 of about 56,937 (260)

A global perspective on the convergence of hypervirulence and carbapenem resistance in Klebsiella pneumoniae

open access: yesJournal of Global Antimicrobial Resistance, 2021
Hypervirulence and carbapenem resistance have emerged as two distinct evolutionary directions for Klebsiella pneumoniae, which pose a great threat in clinical settings.
Peng Lan   +3 more
doaj   +1 more source

Molecular characteristics and antimicrobial resistance profiles of Carbapenem-Resistant Klebsiella pneumoniae isolates at a tertiary hospital in Nanning, China

open access: yesBMC Microbiology, 2023
Purpose Carbapenem resistant Klebsiella pneumoniae is associated with nosocomial infections and can cause high mortality, which poses great threat to human health.
Xianzhen Wei   +5 more
doaj   +1 more source

Monooxygenases and Antibiotic Resistance: A Focus on Carbapenems

open access: yesBiology, 2023
Carbapenems are a group of broad-spectrum beta-lactam antibiotics that in many cases are the last effective defense against infections caused by multidrug-resistant bacteria, such as some strains of Klebsiella pneumoniae, Escherichia coli, Pseudomonas aeruginosa, and Acinetobacter baumannii.
Minerdi, Daniela   +2 more
openaire   +4 more sources

Primers encoding for carbapenem-resistance.

open access: yes, 2023
Primers encoding for carbapenem-resistance.
Rael J. Too (14664679)   +5 more
core   +1 more source

Genome-wide identification of carbapenem-resistant Gram-negative bacterial (CR-GNB) isolates retrieved from hospitalized patients in Bihar, India

open access: yesScientific Reports, 2022
Carbapenemase-producing clinical isolates are becoming more common over the world, posing a severe public health danger, particularly in developing nations like India.
Namrata Kumari   +7 more
doaj   +1 more source

Concomitant Carbapenem and Colistin Resistance among Escherichia coli and Klebsiella pneumoniae Isolates from Patients Visiting a Hospital in Haryana, India

open access: yesMedical Journal of Dr. D.Y. Patil Vidyapeeth, 2023
Background: Increasing prevalence of carbapenem resistance among Enterobacterales, particularly Escherichia coli and Klebsiella pneumoniae, poses a serious public health threat globally.
Leimapokpam Sumitra Devi   +2 more
doaj   +1 more source

Evaluation of Resistance Mechanisms in Carbapenem-Resistant Enterobacteriaceae.

open access: yesInfection and drug resistance, 2020
Carbapenem-resistant Enterobacteriaceae (CRE) is a major concern leading to morbidity and mortality in the world. CRE often is becoming a cause of therapeutic failure in both hospital and community-acquired infections.This study aimed to investigate the resistance mechanisms of CRE by phenotypic and molecular methods.Sixty CRE (50 Klebsiella pneumoniae,
Alizadeh,Naser   +9 more
openaire   +4 more sources

Carbapenem-Resistant Enterobacteriaceae: Epidemiology and Prevention [PDF]

open access: yesClinical Infectious Diseases, 2011
Over the past 10 years, dissemination of Klebsiella pneumoniae carbapenemase (KPC) has led to an increase in the prevalence of carbapenem-resistant Enterobacteriaceae (CRE) in the United States. Infections caused by CRE have limited treatment options and have been associated with high mortality rates. In the previous year, other carbapenemase subtypes,
Neil, Gupta   +3 more
openaire   +2 more sources

Association of Carbapenem and Colistin Resistance in Pathogenic Gram Negative Bacteria

open access: yes, 2019
Diseases caused by multidrug-resistant (MDR) bacteria continue to challenge physicians and endanger their patients’ lives. Polymyxins, including colistin, are the last resort antibiotics to treat serious infections caused by carbapenem-resistant ...
Walid Bakeer   +3 more
core   +1 more source

The Challenge of Overcoming Antibiotic Resistance in Carbapenem-Resistant Gram-Negative Bacteria: “Attack on Titan”

open access: yes, 2023
The global burden of bacterial resistance remains one of the most serious public health concerns. Infections caused by multidrug-resistant (MDR) bacteria in critically ill patients require immediate empirical treatment, which may not only be ineffective ...
Silvia De Gaetano   +4 more
core   +1 more source

Home - About - Disclaimer - Privacy